Community

Thierry Abribat, Ph.D.

Founder and Chief Executive Officer, Amolyt Pharma

Thierry Abribat is a biotech entrepreneur who has founded and managed three biotech companies, one of which, Alizé Pharma 2, was acquired by Jazz Pharmaceuticals (Nasdaq: JAZZ) and another, Alizé Pharma, which was acquired by Millendo Therapeutics (Nasdaq: MLND). Prior to founding Alizé Pharma, he held several executive positions with increasing responsibilities in drug development, business development, and management at Theratechnologies (TSX: TH) and at OPi, Pharmaceuticals for Rare Diseases, until OPi’s acquisition by EUSA Pharma Inc. Thierry began his career as a scientist for Sanofi, then at the University of Montreal, and as a consultant to the biopharmaceutical industry. He holds a Doctorate of Veterinary Medicine and a Ph.D. from the National Polytechnic Institute of Toulouse.

Community

Thierry Abribat, Ph.D.

Founder and Chief Executive Officer, Amolyt Pharma

Contributions

Q: What’s the key to being a leader in the industry?